PTC299 for Treatment of Neurofibromatosis Type 2

NCT00911248 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurofibromatosis 2

Interventions

DRUG: PTC299

Sponsor

PTC Therapeutics

Collaborators

[object Object]